Quest Diagnostics (DGX) Tops Q1 EPS by 4c
Tweet
Share
E-mail
Get Alerts DGX Hot Sheet
Price: $235.50 -0.69%
EPS Growth %: +10.0%
Financial Fact:
Net income attributable to Quest Diagnostics: 192M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +10.0%
Financial Fact:
Net income attributable to Quest Diagnostics: 192M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Quest Diagnostics (NYSE: DGX) reported Q1 EPS of $1.40, $0.04 better than the analyst estimate of $1.36. Revenue for the quarter came in at $1.89 billion versus the consensus estimate of $1.87 billion.
- Outlook for full-year 2019 remains unchanged
For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Quest Diagnostics (DGX) PT Raised to $245 at UBS
- Canaan Inc. (CAN) PT Lowered to $2 at BTIG
- Braze, Inc. (BRZE) Tops Q2 EPS by 4c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
